000 04512nam a22004335i 4500
001 978-1-4419-9902-3
003 DE-He213
005 20140220083731.0
007 cr nn 008mamaa
008 110702s2011 xxu| s |||| 0|eng d
020 _a9781441999023
_9978-1-4419-9902-3
024 7 _a10.1007/978-1-4419-9902-3
_2doi
050 4 _aRM1-950
072 7 _aMMG
_2bicssc
072 7 _aMED071000
_2bisacsh
082 0 4 _a615
_223
100 1 _aZanders, Edward D.
_eauthor.
245 1 4 _aThe Science and Business of Drug Discovery
_h[electronic resource] :
_bDemystifying the Jargon /
_cby Edward D. Zanders.
250 _a1st.
264 1 _aBoston, MA :
_bSpringer US,
_c2011.
300 _aXVII, 397p. 109 illus., 19 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aIntroduction -- Introduction to Drugs and Drug Targets -- Background to Chemistry of Small and Large Molecules -- Laying the Foundations: Drug Discovery from Antiquity to the Twenty-First Century -- Drug Discovery Pipeline Overview -- Target Discovery -- Medicinal Chemistry -- Biotherapeutics -- Screening for Hits -- Process Chemistry and Formulation -- Preclinical Development -- Clinical Trials -- Regulatory Affairs and Marketing Approval -- Diagnostics and Personalized Medicine -- Putting it All Together: A Drug Development Case History -- Commercial Aspects of Drug Development -- Challenges and Responses -- Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical Translators and Interpreters.
520 _aThe Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the nineteen chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices. The following topics are covered: Different types of drugs: from small molecules to stem cells Background to chemistry of small and large molecules Historical background to drug discovery, pharmacology and biotechnology The drug discovery pipeline: from target discovery to marketed medicine Commercial aspects of drug discovery Challenges to the biopharmaceutical industry and its responses Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators   About the Author Dr. Edward D. Zanders has over twenty years’ experience as a scientist and research manager in both a major pharmaceutical company and in smaller biotechnology organizations. He has been responsible for a number of drug discovery programs for diseases such as asthma and rheumatoid arthritis and has been involved in research management at a senior level. He has also published extensively on subjects ranging from biochemistry and immunology to computer-aided drug design; more recently he has written about the application of online networking to drug discovery. In 2004 he founded PharmaGuide Ltd, a training and consultancy company that delivers courses on the drug discovery industry to various professional groups including technology transfer executives, recruiters and technical translators. It is through delivering these courses that he has been able to develop his own way of conveying complex information about drug discovery to non scientists, while at the same time being able to communicate with PhD level scientists at their level of expertise.
650 0 _aMedicine.
650 0 _aToxicology.
650 1 4 _aBiomedicine.
650 2 4 _aPharmacology/Toxicology.
650 2 4 _aBiomedicine general.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781441999016
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4419-9902-3
912 _aZDB-2-SBL
999 _c106151
_d106151